SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 128 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2015. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $28,000 | -69.6% | 256,124 | +373.4% | 0.00% | – |
| Q3 2018 | $92,000 | -2.1% | 54,105 | -0.1% | 0.00% | – |
| Q2 2018 | $94,000 | +9300.0% | 54,156 | +9205.2% | 0.00% | – |
| Q1 2018 | $1,000 | -99.3% | 582 | -99.1% | 0.00% | – |
| Q4 2017 | $142,000 | -57.6% | 63,853 | -44.7% | 0.00% | – |
| Q3 2017 | $335,000 | +3250.0% | 115,511 | +5196.2% | 0.00% | – |
| Q2 2017 | $10,000 | +233.3% | 2,181 | +274.7% | 0.00% | – |
| Q1 2017 | $3,000 | 0.0% | 582 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | -98.4% | 582 | -98.2% | 0.00% | – |
| Q3 2016 | $182,000 | +44.4% | 33,103 | 0.0% | 0.00% | – |
| Q2 2016 | $126,000 | – | 33,103 | +20208.6% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 163 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | – | 163 | +270.5% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 44 | -97.8% | 0.00% | – |
| Q3 2014 | $6,000 | -62.5% | 2,000 | -50.9% | 0.00% | – |
| Q2 2014 | $16,000 | +45.5% | 4,070 | +103.5% | 0.00% | – |
| Q1 2014 | $11,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2013 | $11,000 | +22.2% | 2,000 | 0.0% | 0.00% | – |
| Q3 2013 | $9,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2013 | $9,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nantahala Capital Management | 11,578,568 | $20,147,000 | 0.82% |
| Virtus ETF Advisers LLC | 441,461 | $768,000 | 0.68% |
| Hikari Power Ltd | 2,300,000 | $4,002,000 | 0.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,403,149 | $2,441,000 | 0.17% |
| KNOTT DAVID M | 225,400 | $392,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 277,110 | $482,000 | 0.09% |
| Malaga Cove Capital, LLC | 97,264 | $169,000 | 0.09% |
| Lehman Financial Resources, Inc. | 80,800 | $140,000 | 0.07% |
| Cheyne Capital Management (UK) LLP | 50,000 | $87,000 | 0.06% |
| Ballew Advisors, Inc | 26,200 | $46,000 | 0.05% |